Claudia Dollins – Virtual Presenter

Claudia Dollins – Virtual Presenter

Company: Bristol Myers Squibb

Job title: Executive Director, Regulatory Affairs, Companion Diagnostics & Precision Medicine


Panel Discussion: Incorporation of Artificial Intelligence into Clinical Development Strategy: Best Practices & Pitfalls 4:45 pm

• What are some potential advantages that AI can confer to clinical development programmes? • When might an AI algorithm work better than a traditional statistical approach as a diagnostic, and when might it be unnecessary or inappropriate? • What additional work or risks are involved in developing an AI-based algorithm to support clinical development?…Read more

day: Track A - Day 1 pm

Regulation Panel Discussion: Scaling a Biomarker Test to Global Markets 5:25 pm

• Discussing the nuances in regulatory approvals and launching drug & diagnostic products in different markets (US, EU, APAC) • The importance of China as a market and why industry should come together more to discuss streamlining infrastructure planning and data handling protection to lower costs and planning time when launching biomarker-driven drug programmesRead more

day: Track B - Day 1 pm

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.